282 related articles for article (PubMed ID: 2935755)
1. Low dose hepatitis B vaccination in children.
Milne A; Allwood GK; Pearce NE; Lucas CR; Krugman S
N Z Med J; 1986 Feb; 99(795):47-9. PubMed ID: 2935755
[TBL] [Abstract][Full Text] [Related]
2. Intramuscular versus low-dose intradermal hepatitis B vaccine. Assessment by humoral and cellular immune response to hepatitis B surface antigen.
Frazer IH; Jones B; Dimitrakakis M; Mackay IR
Med J Aust; 1987 Mar; 146(5):242-5. PubMed ID: 2950303
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the immune response of four different dosages of a yeast-recombinant hepatitis B vaccine in Singapore children: a four-year follow-up study.
Goh KT; Tan KL; Kong KH; Oon CJ; Chan SH
Bull World Health Organ; 1992; 70(2):233-9. PubMed ID: 1600584
[TBL] [Abstract][Full Text] [Related]
4. Low dose hepatitis B vaccination in children: benefit of low dose boosters.
Milne A; Moyes CD; Dimitrakakis M
N Z Med J; 1988 Jun; 101(847 Pt 1):370-1. PubMed ID: 2970604
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis B in children in a high risk New Zealand community, and control using recombinant DNA vaccine.
Milne A; Heydon JL; Hindle RC; Pearce NE
N Z Med J; 1989 Apr; 102(866):182-4. PubMed ID: 2523525
[TBL] [Abstract][Full Text] [Related]
6. Mass vaccination against hepatitis B in preschool children: immunogenicity after three reduced doses.
Milne A; Moyes CD; Waldon J; Pearce NE; Krugman S
N Z Med J; 1989 Aug; 102(874):429-30. PubMed ID: 2527346
[TBL] [Abstract][Full Text] [Related]
7. Persistence of anti-HBs antibody and immunological memory in children vaccinated with hepatitis B vaccine at birth.
Jafarzadeh A; Montazerifar SJ
J Ayub Med Coll Abbottabad; 2006; 18(4):4-9. PubMed ID: 17591001
[TBL] [Abstract][Full Text] [Related]
8. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal).
Coursaget P; Deciron F; Tortey E; Barin F; Chiron JP; Yvonnet B; Diouf C; Denis F; Diop-Mar I; Correa P
IARC Sci Publ; 1984; (63):319-35. PubMed ID: 6242150
[TBL] [Abstract][Full Text] [Related]
9. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children.
Yuen MF; Lim WL; Cheng CC; Lam SK; Lai CL
Hepatology; 1999 Mar; 29(3):924-7. PubMed ID: 10051499
[TBL] [Abstract][Full Text] [Related]
10. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.
Gandhi RT; Wurcel A; Lee H; McGovern B; Shopis J; Geary M; Sivamurthy R; Sax PE; Ukomadu C
J Infect Dis; 2005 May; 191(9):1435-41. PubMed ID: 15809901
[TBL] [Abstract][Full Text] [Related]
11. Clinical trial of hepatitis B vaccine in a simplified immunization programme.
Coursaget P; Yvonnet B; Sarr M; Vincelot P; Tortey E; Mboup S; Chiron JP; Diop-Mar I
Bull World Health Organ; 1986; 64(6):867-71. PubMed ID: 2951032
[TBL] [Abstract][Full Text] [Related]
12. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B vaccine in developing countries: problems and prospects.
Ayoola EA
IARC Sci Publ; 1984; (63):297-305. PubMed ID: 6242148
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the effectiveness nine years after primary immunization with local produced plasma-derived hepatitis B vaccine].
Xu H; Zuo H; Zhuang G
Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jul; 32(4):205-7. PubMed ID: 10322755
[TBL] [Abstract][Full Text] [Related]
15. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
Gunn TR; Bosley A; Woodfield DG
N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
[TBL] [Abstract][Full Text] [Related]
16. Intradermal administration of hepatitis B vaccine in infants and preschool children.
Kurugöl Z; Egemen A; Erensoy S; Bilgiç A; Kütükçüler N
Turk J Pediatr; 1997; 39(4):483-9. PubMed ID: 9433150
[TBL] [Abstract][Full Text] [Related]
17. The response of isolated anti-HBc positive subjects to recombinant hepatitis B vaccine.
Ural O; Findik D
J Infect; 2001 Oct; 43(3):187-90. PubMed ID: 11798257
[TBL] [Abstract][Full Text] [Related]
18. [A five-year observation on efficacy of revaccination in children of non-response to hepatitis B vaccine].
Zhuang GH; Yan H; Wang XL; Wu Q; Wang LR; Gao HY
Zhonghua Yu Fang Yi Xue Za Zhi; 2006 Jan; 40(1):8-12. PubMed ID: 16620590
[TBL] [Abstract][Full Text] [Related]
19. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
20. Antibody responses to recombinant, yeast-derived hepatitis B vaccine in teenage New Zealand children.
Milne A; Moyes CD; Allwood GK; Pearce NE; Krugman S
N Z Med J; 1988 Feb; 101(840):67-9. PubMed ID: 2967940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
